Chat with us
Research Assistance
Online
  • Please enter your first name.

Argentina Oral Solid Dosage Contract Manufacturing Market Size & Outlook

The oral solid dosage contract manufacturing market in Argentina is expected to reach a projected revenue of US$ 277.5 million by 2030. A compound annual growth rate of 5.5% is expected of Argentina oral solid dosage contract manufacturing market from 2025 to 2030.

  • HC Outsourcing
    • CMO/CDMO
      • Oral Solid Dosage Contract Manufacturing Market Outlook
Revenue, 2024 (US$M)
$201.5
Forecast, 2030 (US$M)
$277.5
CAGR, 2025 - 2030
5.5%
Report Coverage
Argentina

Argentina Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (US$M)

Argentina Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Report

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the oral solid dosage contract manufacturing market

Every figure cited from GVR research

Argentina oral solid dosage contract manufacturing market highlights

  • The Argentina oral solid dosage contract manufacturing market generated a revenue of USD 201.5 million in 2024 and is expected to reach USD 277.5 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 5.5% from 2025 to 2030.
  • In terms of segment, tablets was the largest revenue generating product in 2024.
  • Capsules is the most lucrative product segment registering the fastest growth during the forecast period.

Oral solid dosage contract manufacturing market data book summary

Market revenue in 2024USD 201.5 million
Market revenue in 2030USD 277.5 million
Growth rate5.5% (CAGR from 2025 to 2030)
Largest segmentTablets
Fastest growing segmentCapsules
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTablets, Capsules, Powders, Granules
Key market players worldwideCatalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc

Other key industry trends

  • In terms of revenue, Argentina accounted for 0.5% of the oral solid dosage contract manufacturing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil oral solid dosage contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 2,584.5 million by 2030.

The Argentina oral solid dosage contract manufacturing market is expected to exhibit lucrative growth in the coming years owing to increasing demand for generic drugs, prevalence of diseases, and favorable regulatory environment. In addition, the country has extensive experience in foreign investments in the sector, and it offers business opportunities while representing commercial growth.

The country is regarded as a favorable location for tablet production facilities, which plays a key role in bringing innovative drugs to the global marketplace with cost-effective clinical trials in the Latin American region. It further enhances the market product offerings by adding a solid oral dosage capability addressing the consumer need and diseases burden in the country.

No credit card required*

Publish Date: Apr 30, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oral Solid Dosage Contract Manufacturing Market Companies

NameProfile# EmployeesHQWebsite
AbbVie IncView profile 50,0001 North Waukegan Road, North Chicago, IL, United States, 60064-6400www.abbvieinvestor.com
Lonza Group LtdView profile 18,000Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002www.lonza.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Boehringer IngelheimView profile 10001+Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europewww.boehringer-ingelheim.com/
Catalent IncView profile 17,21914 Schoolhouse Road, Somerset, NJ, United States, 08873www.catalent.com
Siegfried Holding AGView profile 4,180Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800www.siegfried.ch
RecipharmView profile 1001-5000Jordbro, Stockholms Lan, Sweden, Europewww.recipharm.com
Piramal Pharma SolutionsView profile 1001-5000Riverview, Michigan, United States, North Americawww.piramalpharmasolutions.com/
CordenPharmaView profile 5001-10000Plankstadt, Baden-Wurttemberg, Germany, Europecordenpharma.com
Jubilant PharmovaView profile 10001+Noida, Uttar Pradesh, India, Asiawww.jubilantpharmova.com

Argentina Oral Solid Dosage Contract Manufacturing Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oral Solid Dosage Contract Manufacturing Market Outlook will help companies and investors design strategic landscapes.


Tablets was the largest segment with a revenue share of 33.45% in 2024.

Horizon Databook has segmented the Argentina oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.




The Argentina oral solid dosage contract manufacturing market is expected to exhibit lucrative growth in the coming years owing to increasing demand for generic drugs, prevalence of diseases, and favorable regulatory environment. In addition, the country has extensive experience in foreign investments in the sector, and it offers business opportunities while representing commercial growth.

The country is regarded as a favorable location for tablet production facilities, which plays a key role in bringing innovative drugs to the global marketplace with cost-effective clinical trials in the Latin American region. It further enhances the market product offerings by adding a solid oral dosage capability addressing the consumer need and diseases burden in the country.

  • Argentina Oral Solid Dosage Contract Manufacturing Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Tablets
    • Capsules
    • Powders
    • Granules
    • Others
  • Argentina Oral Solid Dosage Contract Manufacturing Market Mechanism Outlook (Revenue, USD Million , 2018-2030)
    • Immediate Release
    • Delayed Release
    • Controlled Release
  • Argentina Oral Solid Dosage Contract Manufacturing Market End User Outlook (Revenue, USD Million , 2018-2030)
    • Large Size Companies
    • Medium & Small Size Companies
    • Others

Reasons to subscribe to Oral Solid Dosage Contract Manufacturing Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Oral Solid Dosage Contract Manufacturing Market Outlook databook

  • Our clientele includes a mix of Oral Solid Dosage Contract Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina Oral Solid Dosage Contract Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Argentina Oral Solid Dosage Contract Manufacturing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Argentina Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (US$M)

No Access Stack Chart

Argentina Product - Oral Solid Dosage Contract Manufacturing Market Statistics, 2024 - 2030 (US$M)

No Access Pie Chart

Argentina Product - Oral Solid Dosage Contract Manufacturing Market Statistics, 2024 - 2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more